ANDA litigation refers to legal disputes that arise between a brand-name drug patent holder and a generic drug manufacturer following the submission of an Abbreviated New Drug Application (ANDA) by the generic manufacturer.
This tab offers Overall, Brand, and Generic details that you can view for a selected time range.
Overall, Brand, and Generic details
| Option | Description |
| Cases | Number of cases with this entity. |
| Unique Patents | Number of unique patents involved in the district court cases for a selected time range. |
| District Courts | Number of district courts where the cases have taken place |
| Clients | Number of clients represented by the entity (law firm/attorney/company) |
| Activity & Performance (Overall, Brand, and Generic) | This section shows the activity and performance scores earned by the entity in the Patexia rankings.For more details, refer to the section Activity & Performance (Ranking and Score). |
| Cases | BreakdownThe chart shows the number of cases per year or per month. Appeal RatioThe chart shows the percentage of cases that were appealed/not appealed. Unique PatentsThe chart shows the number of unique patents litigated per year or per month.Note: This information is available under the Subscription-Only plan. For details on the subscription process, refer to the section Getting Started with Patexia Concierge. |
| Outcomes | The Sankey diagram showcases the flow of cases through various stages. For more details, refer to the section Outcomes. |
| Professional Ecosystem | This section includes tabs covering the entity’s top 5 colleagues, clients, conflicts, judges, and courts related to their cases.For more details, refer to the section Professional Ecosystem. |
| Technology Centers | This section shows the top technology centers of the entity’s patents.For more details, refer to the section Technology Centers. |
| Litigation List | The table shows cases in which the entity has participated.For more details, refer to the section Litigation List. |
